| Oct 7 |
Gilead upgraded to overweight by Wells Fargo, PrEP launch cited
|
| Oct 7 |
AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history
|
| Oct 5 |
Consider Buying Gilead To Benefit From Its Strong Outlook, Favorable Valuation
|
| Oct 5 |
Gilead Sciences' (NASDAQ:GILD) investors will be pleased with their favorable 62% return over the last five years
|
| Oct 4 |
Peeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights
|
| Oct 4 |
Praxis Precision Medicines (PRAX) Moves 8.4% Higher: Will This Strength Last?
|
| Oct 3 |
GILD Grants Right for HIV PrEP Candidate to Six Generic Companies
|
| Oct 3 |
Gilead signs agreements to facilitate access to HIV prevention drug
|
| Oct 2 |
Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
|
| Oct 2 |
Gilead signs deals with six drugmakers for generic lenacapavir
|
